Showing results (171-180 of 203) with videos related to
Sort By:
Pageof 21
Immunity|December 21, 2010
The 2.5 Å structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentationLouise Scharf, Nan-Sheng Li, Andrew J Hawk, et al.Chemmedchem|December 23, 2024
Elucidating the High Affinity Copper(II) Complexation by the Iron Chelator Deferasirox Provides Therapeutic and Toxicity InsightAixa M Orta Rivera, Luis A Landrau Correa, Selene L Schiavone-Chamorro, et al.Scientific Reports|February 28, 2017
Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistanceJohn R Grünberg, Jenny M Hoffmann, Shahram Hedjazifar, et al.Nature Communications|May 30, 2024
Inflammation causes insulin resistance in mice via interferon regulatory factor 3 (IRF3)-mediated reduction in FAHFA levelsShuai Yan, Anna Santoro, Micah J Niphakis, et al.Cell|October 11, 2014
Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effectsMark M Yore, Ismail Syed, Pedro M Moraes-Vieira, et al.Plos One|December 7, 2017
Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapyMaya Saison-Ridinger, Kathleen E DelGiorno, Tejia Zhang, et al.Inorganics|April 29, 2021
Iron and Copper Intracellular Chelation as an Anticancer Drug StrategyKavita Gaur, Alexandra M Vázquez-Salgado, Geraldo Duran-Camacho, et al.JACS Au|July 9, 2021
Iron Chelator Transmetalative Approach to Inhibit Human Ribonucleotide ReductaseKavita Gaur, Sofia C Pérez Otero, Josué A Benjamín-Rivera, et al.Inorganics|October 9, 2024
Copper-Based Antibiotic Strategies: Exploring Applications in the Hospital Setting and the Targeting of Cu Regulatory Pathways and Current Drug Design TrendsAixa M Orta-Rivera, Yazmary Meléndez-Contés, Nataniel Medina-Berríos, et al.Cell Metabolism|January 3, 2017
SREBP1 Contributes to Resolution of Pro-inflammatory TLR4 Signaling by Reprogramming Fatty Acid MetabolismYumiko Oishi, Nathanael J Spann, Verena M Link, et al.Pageof 21